Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  43 results for ""Receptor, EphA2""

Your Filters

Subject : melanoma
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Conformational Clamping by a Membrane Ligand Activates the EphA2 Receptor.

  • Authors : Westerfield JM; Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, 1311 Cumberland Avenue, Knoxville, TN 37996, USA.; Sahoo AR

Subjects: Protein Conformation*; Melanoma/Melanoma/Melanoma/*pathology ; Membrane Proteins/Membrane Proteins/Membrane Proteins/*metabolism

  • Source: Journal of molecular biology [J Mol Biol] 2021 Sep 03; Vol. 433 (18), pp. 167144. Date of Electronic Publication: 2021 Jul 03.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 2985088R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Noncanonical EphA2 Signaling Is a Driver of Tumor-Endothelial Cell Interactions and Metastatic Dissemination in BRAF Inhibitor‒Resistant Melanoma.

  • Authors : Zhang C; The Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.; Smalley I

Subjects: Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics ; Melanoma/Melanoma/Melanoma/*drug therapy ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*pharmacology

  • Source: The Journal of investigative dermatology [J Invest Dermatol] 2021 Apr; Vol. 141 (4), pp. 840-851.e4. Date of Electronic Publication: 2020 Sep 02.Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p.

  • Authors : Chen X; Department of Dermatologic Surgery, Shanghai Skin Disease Hospital, Shanghai, China.; Tang Y

Subjects: Melanoma/Melanoma/Melanoma/*genetics ; MicroRNAs/MicroRNAs/MicroRNAs/*metabolism ; RNA, Circular/RNA, Circular/RNA, Circular/*metabolism

  • Source: Journal of dermatological science [J Dermatol Sci] 2021 Sep; Vol. 103 (3), pp. 176-182. Date of Electronic Publication: 2021 Aug 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9011485 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.

  • Authors : Mo J; Department of Pathology, Tianjin Medical University, 300070, Tianjin, China.; Department of Pathology, General Hospital of Tianjin Medical University, 300052, Tianjin, China.

Subjects: Melanoma/Melanoma/Melanoma/*metabolism ; Melanoma/Melanoma/Melanoma/*pathology ; Receptor, EphA1/Receptor, EphA1/Receptor, EphA1/*metabolism

  • Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2020 Aug; Vol. 43 (4), pp. 655-667. Date of Electronic Publication: 2020 Apr 14.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

[Expression of EphA2 in Metastatic and Non-Metastatic Primary Uveal Melanoma].

Subjects: Gene Expression Regulation, Neoplastic*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Melanoma/Melanoma/Melanoma/*physiopathology

  • Source: Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2016 Mar; Vol. 232 (3), pp. 290-7. Date of Electronic Publication: 2016 Feb 08.Publisher: Thieme Country of Publication: Germany NLM ID: 0014133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-3999

Record details

Read More Add to Saved list
×
Academic Journal

EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.

  • Authors : Miao B; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts. Department of Dermatology, Harvard Medical School, Boston, Massachusetts.; Ji Z

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*genetics ; Indoles/Indoles/Indoles/*pharmacology

  • Source: Cancer discovery [Cancer Discov] 2015 Mar; Vol. 5 (3), pp. 274-87. Date of Electronic Publication: 2014 Dec 26.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.

  • Authors : Reissenweber B; Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden University of Technology, Dresden, Germany.; Mosch B

Subjects: Cell Hypoxia/Cell Hypoxia/Cell Hypoxia/*physiology ; Ephrins/Ephrins/Ephrins/*biosynthesis ; Melanoma/Melanoma/Melanoma/*metabolism

  • Source: Melanoma research [Melanoma Res] 2013 Apr; Vol. 23 (2), pp. 85-95.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma.

  • Authors : Chen L; Eye Center of TianJin Medical University, TianJin 300070, PR China.; Sun B

Subjects: Matrix Metalloproteinase 2/Matrix Metalloproteinase 2/Matrix Metalloproteinase 2/*analysis ; Matrix Metalloproteinase 9/Matrix Metalloproteinase 9/Matrix Metalloproteinase 9/*analysis ; Melanoma/Melanoma/Melanoma/*blood supply

  • Source: Oncology reports [Oncol Rep] 2009 Apr; Vol. 21 (4), pp. 917-23.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print ISSN: 1021-335X (Print)

Record details

Read More Add to Saved list
×
Academic Journal

EphA2 as a promoter of melanoma tumorigenicity.

Subjects: Neoplasm Metastasis* ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/genetics ; Receptor, EphA2*/Receptor, EphA2*/Receptor, EphA2*/metabolism

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2009 Feb; Vol. 8 (3), pp. 279-88. Date of Electronic Publication: 2009 Feb 21.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

EphA2 is a critical oncogene in melanoma.

  • Authors : Udayakumar D; Department of Dermatology, Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, MA, USA.; Zhang G

Subjects: Melanoma/Melanoma/Melanoma/*metabolism ; Oncogene Proteins/Oncogene Proteins/Oncogene Proteins/*biosynthesis ; Receptor, EphA2/Receptor, EphA2/Receptor, EphA2/*biosynthesis

  • Source: Oncogene [Oncogene] 2011 Dec 15; Vol. 30 (50), pp. 4921-9. Date of Electronic Publication: 2011 Jun 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  43 results for ""Receptor, EphA2""